Larvol Delta - 89bio-Announces-New-Positive-LongTerm-Data-from-the-ENLIVEN-Phase-2b-Trial-of-Pegozafermin-in-Patients-with-Nonalcoholic-Steatohepatitis-NASH

pegozafermin (BIO89-100) - 89Bio

https://www.globenewswire.com/news-release/2023/11/27/2786131/0/en/89bio-Announces-New-Positive-Long-Term-Data-from-the-ENLIVEN-Phase-2b-Trial-of-Pegozafermin-in-Patients-with-Nonalcoholic-Steatohepatitis-NASH.html

Nov 27, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next